{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-11-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "Y",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "SDA",
      "openfda": {
        "pma_number": [
          "P230042"
        ],
        "registration_number": [
          "2032098",
          "3009746061",
          "3009453079",
          "3010457505",
          "3003639781",
          "3009306483",
          "8043792"
        ],
        "fei_number": [
          "3009746061",
          "3009453079",
          "3010457505",
          "3003639781",
          "3003058448",
          "3002808269",
          "3009306483"
        ]
      },
      "review_panel": "AN",
      "medical_specialty": "",
      "device_name": "Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Unknown",
      "device_class": "3",
      "definition": "Optune Lua concurrent with PD-1/PD-L1 inhibitors or docetaxel is indicated for adult patients with metastatic non-small cell lung cancer who have progressed on or after a platinum-based regimen.",
      "regulation_number": "",
      "implant_flag": "N",
      "submission_type_id": "2"
    }
  ]
}